CERAVER
CERAVER is a French manufacturer of orthopedic prostheses and surgical instruments (hip, knee, spine, biomaterials, dental), founded in 1969 and serving hospitals and surgical teams through direct field sales. The company is part of the XNOV Group.
- Company typePrivate
- Founded1969
- HeadquartersRoissy, France
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What CERAVER does
CERAVER (legal entity: Les Laboratoires Osteal Médical) is a French manufacturer of orthopedic prostheses and surgical instruments founded in 1969 in Roissy CDG, near Paris. The company designs, produces and commercializes implants and instruments across five categories: hip (femoral stems, acetabular cups, dual mobility systems, bipolar heads, alumina ceramic articulations), knee (patellofemoral, unicompartmental, fixed-bearing posterior-stabilized HIFIT, revision HERMES), spine (CERADISC cervical disc prosthesis), surgical instrumentation (anterior approach kits, Dymond spacers, patient-specific customized masks), and biomaterials (CALCIRESORB resorbable bone substitute, CERAFIX acrylic bone cements with and without gentamicin, plus a dental application of CALCIRESORB). Its core technology rests on pioneering use of alumina ceramic (Al2O3) and titanium alloy TiAl6V4 in orthopedics, hydroxyapatite coatings (HAC) for biological fixation, and proprietary concepts such as the triradius metal cup geometry and ACTISURF anti-bacterial surface coating. CERAVER operates two production facilities exceeding 10,000 m² in France and maintains complete vertical control from design through manufacturing.
The company is a privately held Société Anonyme with €1,468,280 share capital, 51-100 employees, and is associated with the XNOV Group as parent entity; it is a former subsidiary of the Alcatel-Alsthom group. Revenue is generated through direct sales of implants and instruments to hospitals and surgical teams in France and, via international medical congress activity, selective overseas markets; pricing is not publicly disclosed. The go-to-motion is enterprise field sales: technically trained representatives support operating-room staff, complemented by a 1,100 m² training academy in Plailly, surgeon education programs, and participation in congresses such as SOFCOT, SFA, AAOS, FIME, ASIA HEALTH and ISAKOS. The site is gated to health professionals (RPPS registration required).
CERAVER holds ISO 13485 certification via GMED, CE marking, and ANSM clinical study authorization (notably for ACTISURF, 2016), and holds European patents including CERADISC (2011). Recent strategic activity has focused on portfolio extension into spine and dental, post-registration clinical evidence generation (EPI PTH CDM study with IQVIA, authorized by CNIL in 2020), and alignment with the XNOV Group ecosystem. The company's competitive positioning emphasizes 50+ years of clinical heritage, in-house French manufacturing, and close collaboration with surgical and scientific teams rather than scale or breadth.
CERAVER firmographics
Firmographics- Name
- CERAVER
- Legal name
- LES LABORATOIRES OSTEAL MÉDICAL
- Website
- https://ceraver.com
- Company type
- Private
- Founded year
- 1969
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- CERAVER is a French manufacturer of orthopedic prostheses and surgical instruments (hip, knee, spine, biomaterials, dental), founded in 1969 and serving hospitals and surgical teams through direct field sales. The company is part of the XNOV Group.
- Ownership category
- akta.pro rank
CERAVER industry classification
Industry- Product category
- Orthopedic Medical Devices
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)
- SIC
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Orthotics & Bracing (Spinal/Lower/Upper Extremity Orthoses) (HLAHAEAI)
- akta.pro secondary industries
- Implant Prosthetics & Abutment Fabrication (HLABAJAC), Medical & Dental Prototyping (Models, Guides, Pre-Op Planning) (IMAAAFAI), Crown & Bridge (Fixed Prosthetics) Fabrication (HLABAJAA)
Keywords
Where CERAVER is headquartered
LocationHeadquarters
- HQ city
- Roissy
- HQ country
- France
- HQ region
- Europe
Offices3 records
Markets served
CERAVER business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure
Revenue model
- Orthopedic prostheses and instruments: CERAVER designs, manufactures, and commercializes high-tech orthopedic products including hip prostheses, knee prostheses, spinal devices, biomaterials, and dental products. Revenue is generated through the sale of implants, surgical instruments, and associated medical devices to hospitals and surgical teams.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
CERAVER product offering
Product offeringCore offering
CERAVER designs, manufactures, and commercializes high-technicality orthopedic prostheses (hip, knee, spine implants), surgical instruments, biomaterials (bone cements, resorbable bone substitutes), and dental bone substitutes. The company controls the entire production process in France, from design through manufacturing and quality control, and sells its products directly to hospitals, orthopedic surgery departments, and surgical teams.
Product overview
CERAVER is a French manufacturer of high-technicality orthopedic prostheses and surgical instruments with over 50 years of experience. The company offers a comprehensive portfolio organized into five main categories: Hip implants (femoral stems, acetabular cups, dual mobility systems, bipolar heads, and alumina ceramic articulations including the pioneering OSTEAL and CERAFIT lines); Knee implants (patellofemoral, unicompartmental, tricompartmental fixed-bearing posterior-stabilized HIFIT, and revision HERMES systems); Spine implants (CERADISC cervical disc prosthesis); Surgical instrumentation (anterior approach tools, Dymond spacers, and patient-specific customized masks); and Biomaterials (CALCIRESORB resorbable bone substitutes and CERAFIX acrylic bone cements with and without antibiotic). Additionally, CERAVER offers dental bone substitute products. The company maintains complete control from design through manufacturing in France, pioneering the use of alumina ceramics and titanium alloys in orthopedics.
Differentiator
Problem solved
Functional benefit
Products and services
- OSTEAL Standard Stem Cemented straight femoral stem for hip replacement, available in standard, coxa vara, and dysplastic femur variants. Compatible with stainless steel and alumina femoral heads; for orthopedic surgeons performing hip arthroplasty.
- OSTEAL Long Revision Stem Cemented revision femoral stem with pertrochanteric support, available up to 300mm length, for complex hip revision cases.
- CERAFIT MULTICÔNES HAC Cementless straight stem with hydroxyapatite coating (HAC) for biological fixation in hip arthroplasty.
- CERAFIT RMIS HAC Low-profile cementless stem with HAC coating designed for Reasonable Minimally Invasive (R-MIS) hip implantation, available in standard (132°) and lateralized (125°) versions.
- Polyethylene Cup Cemented polyethylene acetabular cup with notches for rotational stability and radio-opaque marker, used in hip arthroplasty.
- HAC CERAFIT Cup Cementless acetabular cup in titanium alloy with hydroxyapatite coating and triradius concept for optimal press-fit fixation in hip arthroplasty.
- CERAFIT Dual Mobility Cup Dual mobility acetabular system for hip arthroplasty, available in cemented and cementless (HAC) versions, providing enhanced dislocation resistance.
- Bipolar Head Dual articulation prosthesis for partial hip arthroplasty, with metal cup and polyethylene core accepting 22.2mm or 28mm femoral heads.
- Alumina Head & Liner Pure alumina ceramic femoral heads and liners with 12/14 conical fitting, providing low-wear alumina-alumina articulations for hip replacement.
- HERMES Patellofemoral Prosthesis Patellofemoral prosthesis with trochlea component featuring 6° upward/outward orientation and raised external edge, for partial knee replacement.
- HERMES Unicompartmental Knee Prosthesis Unicompartmental knee prosthesis with cobalt-chrome femoral component and asymmetrical tibial baseplate, for partial knee replacement.
- HIFIT PS Fixed-Bearing Posterior-Stabilized Knee Prosthesis Tricompartmental fixed-bearing posterior-stabilized knee prosthesis with CoCrMo femoral component and UHMWPE tibial insert, for total knee replacement.
- HERMES PS Revision Knee System Revision knee system compatible with HiFit PS, featuring femoral and tibial spacers, extensions, and multi-directional tibial keel excentration for complex knee revisions.
- CERADISC Cervical Disc Prosthesis Cervical disc prosthesis with self-stability and self-centering via double-radius polyethylene core, indicated for cervical spine disc replacement.
- Anterior Approach Instrumentation Complete instrumentation range for anterior hip approach including offset grater holders and acetabular impactors, for hip arthroplasty surgical teams.
- Dymond Spacer Autostatic femoral-cotyloid spacer for acetabulum exposure during preparation, available in left and right versions, supporting hip arthroplasty procedures.
- Customized Masks (Patient-Specific Instrumentation) Patient-specific instrumentation based on CT or MRI scans for pre-operative planning and complex orthopedic case management.
- CALCIRESORB (Resorbable Bone Substitute) Resorbable synthetic bone substitute made of 100% beta-tricalcium phosphate (β-TCP) with interconnected macroporous architecture for osteoconduction in orthopedic filling applications.
- CERAFIX & CERAFIXGENTA Bone Cements Acrylic bone cements available in high viscosity (HV) and low viscosity (BV) versions, with or without gentamicin antibiotic, for implant fixation in orthopedic surgery.
- CALCIRESORB Classic (Dental Application) Resorbable β-tricalcium phosphate bone substitute in 0.5–1mm fragments for maxillofacial and dental surgery applications.
Companies that use CERAVER
Customer profileSegments1 record
Ideal customer profiles1 record
CERAVER technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
CERAVER partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- IQVIA Opérations FranceminorIQVIA Opérations France (17 bis Place des Reflets, 92400 Courbevoie) is delegated by CERAVER (OSTEAL MEDICAL LABORATORIES) to implement the EPI PTH CDM study - a post-registration study for comprehensive follow-up of patients with total hip replacements with dual mobility cups. The study was assessed as being in public interest by CESREES on December 10, 2020 and authorized by CNIL.
Scale indicators4 records
Recent moves6 records
Expansion highlights6 records
CERAVER competitors and assessment
Company assessmentBroad incumbents
- Stryker: Global orthopedic implant major with broad hip, knee, and spine franchises including Mako robotics; competitor to CERAVER in hip and knee replacement but at vastly greater scale with full multinational distribution.
- DePuy Synthes (Johnson & Johnson): Johnson & Johnson's orthopedic franchise with hip, knee, and spine implants; broad incumbent that competes across nearly all of CERAVER's product lines including cervical disc and biomaterials channels.
- Zimmer Biomet: One of the largest global orthopedic implant manufacturers with leading hip, knee, and cement franchises; competes directly with CERAVER in ceramic-on-ceramic bearings and bone cements with vastly greater R&D and clinical investment capacity.
- Enovis (DJO): Orthopedic and surgical implant manufacturer with hip products including the EMPOWR and AltiVate lines plus bracing and instrumentation; competes with CERAVER in hip arthroplasty with broader portfolio scope.
- Smith+Nephew: Global medical device company with significant hip and knee implant business alongside wound care and sports medicine; broad incumbent that overlaps with CERAVER in primary and revision joint replacement.
Direct peers
- Adler Ortho: Italian orthopedic implant specialist focused on hip and knee prostheses; comparable niche European manufacturer with direct sales model and clinical-driven product innovation similar to CERAVER's heritage.
- Mathys (European Orthopaedics): Swiss orthopedic specialist with hip and knee replacement franchises including ceramic-on-ceramic bearings; most analogous European mid-size implant specialist by therapeutic focus, geography, and distribution model.
- Corin: UK-based mid-size orthopedic implant specialist focused on hip, knee, and ankle prostheses; closely comparable to CERAVER as a premium-positioned European orthopedic manufacturer with proprietary bearing surface technology and similar surgeon-led GTM.
- Aston Medical: French orthopedic implant manufacturer specializing in hip and knee prostheses; directly competes with CERAVER in the same French hospital market with overlapping product lines and similar direct-sales-to-surgical-teams model.
- Dedienne Santé: French orthopedic implant manufacturer focused on hip, knee, and shoulder prostheses; similar mid-size French specialist competing in the same domestic hospital market with comparable product breadth.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
CERAVER social profiles
Digital presenceCERAVER compliance and trust
Trust signalCompliance1 record
CERAVER financial estimates
Financial estimateRevenue estimate
Valuation estimate
CERAVER leadership team
Management profileNumber of profiles
Profiles4 records
CERAVER funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CERAVER M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CERAVER
What does CERAVER do?
CERAVER designs, manufactures, and commercializes high-technicality orthopedic prostheses (hip, knee, spine implants), surgical instruments, biomaterials (bone cements, resorbable bone substitutes), and dental bone substitutes. The company controls the entire production process in France, from design through manufacturing and quality control, and sells its products directly to hospitals, orthopedic surgery departments, and surgical teams.
Is CERAVER a public or private company?
CERAVER is a private company. It is classified as corporate owned and is currently operating.
When was CERAVER founded?
CERAVER was founded in 1969. It employs 11 to 50 people.
Where is CERAVER based?
CERAVER is headquartered in Roissy, France, in the Europe region.
How does CERAVER make money?
One revenue line is on record: orthopedic prostheses and instruments.
Who are CERAVER's main competitors?
Broad incumbents on record are Stryker, DePuy Synthes (Johnson & Johnson), Zimmer Biomet, Enovis (DJO) and Smith+Nephew. Direct peers are Adler Ortho, Mathys (European Orthopaedics), Corin, Aston Medical and Dedienne Santé.
Does CERAVER have an API?
No public API is recorded for CERAVER.
What industry is CERAVER in?
CERAVER's product category is Orthopedic Medical Devices. Its primary akta.pro industry code is HLAHAEAI, Orthotics & Bracing (Spinal/Lower/Upper Extremity Orthoses), with a secondary code of HLABAJAC, Implant Prosthetics & Abutment Fabrication. Its NAICS code is 339113 and its SIC code is 3842.